about
CD40 in coronary artery disease: a matter of macrophages?From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisQuaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.Nanomedicine as a strategy to fight thrombotic diseases.Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and AtherosclerosisAtherosclerosis.Association of polymorphisms in the MAFB gene and the risk of coronary artery disease and ischemic stroke: a case-control studyBeyond vascular inflammation--recent advances in understanding atherosclerosis.Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosisAtheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progressionLabeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography.Age-associated vascular inflammation promotes monocytosis during atherogenesis.Characterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE-/- Reporter Mouse-Brief Report.Scavenger receptors and non-coding RNAs: relevance in atherogenesis.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection.MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases.Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation.Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.The melding of nanomedicine in thrombosis imaging and treatment: a review.Natural killer T cells in atherosclerosis.Gold nanoparticles in cardiovascular imaging.Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults.Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation.Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II.Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice.The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis.Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome.Cardiovascular Immunotherapy and the Role of Imaging.Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages.Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.Identification of Smoking-Associated Differentially Methylated Regions Using Reduced Representation Bisulfite Sequencing and Cell type-Specific Enhancer Activation and Gene Expression.Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
P2860
Q26752784-4900DB6E-F86D-4CD0-A912-C3EE188319ABQ26770209-E691233E-37F7-4C50-BB75-B817FFDED907Q26780531-4165E923-7655-4E1D-A3F3-EBF899A3EADBQ27328830-3A090EC4-8B6E-44EC-BB54-13AF2430CE66Q30367197-EC3D7652-9D7C-4133-AF10-FA5DEF04D215Q30853668-C2D9476D-681D-4298-A6BC-58C382E8E1D0Q35879603-BF0ED8F1-0B3F-460E-9E5B-2337138C10C8Q35885587-5A8FDBBF-454B-445B-82CC-21A1535BD7EFQ36079808-ECC0EE8A-3FF5-49F4-BF37-22323D11DC39Q36337990-09F1F5F5-E20D-401E-AAD9-0BC584C4A88CQ36594764-B2960C3D-D5B9-4835-ADFD-76A27F9A96DAQ36665318-45DF5C01-9CB4-4EC1-858E-B0FD131B6682Q37066948-429DF3DB-F91A-4DCB-B1A5-37C6BF4E8ED8Q37240505-E8AE756C-8F02-4635-A936-F2E74AC82C24Q37611168-AE9A0772-0397-4913-800D-3A3F182AB495Q38608471-47051C00-EEEE-410E-9622-D84D10F2CCEAQ38620803-3068203E-A0CE-4E87-BC69-8CB764C6DACFQ38701621-396BD2C6-728D-44C5-83D8-F196CF398A1FQ38716293-029A5D67-51C9-4EC2-9B26-06658153D0E8Q38770370-1C3ED2ED-4819-4F08-B8E9-965FF9A28875Q38773475-08B114FD-62FB-43EC-BC49-572B6351656BQ38776819-CAC08AB6-B773-456D-82C6-1F603B538DBBQ39105646-251F9CB5-585A-4645-85D5-F85B3A62B1E0Q39223803-5BE784D0-B0FA-4A54-B810-71FA8A7101A7Q41433893-81DA2BDB-A236-47A1-ABB2-75329B0754DFQ47103073-77A7749C-33F3-43D2-9B0E-512B199315FBQ47193091-80EA0BEA-7583-4653-866D-ED18CCBD02DFQ48148178-CC2AD6AC-6AFB-47A2-9ABE-80624AA46E9DQ49190975-E55AE0FD-1276-4781-A74B-75CD86E13565Q49215161-986DB6E4-F7F6-47D6-96B8-FAF56B112295Q50044386-D65210F8-7B6C-4ED1-B61E-BAC189E7FBC1Q50047580-29A17491-DB93-43DD-8F55-43192D280C32Q50085133-5C0CD1E7-125A-4EAC-A852-1CD52C89AC7FQ51031177-2E2D57A0-2E3B-482F-AD12-BAC94385051AQ52653300-9EE11771-E5CF-4383-B039-1363B4A1913DQ52715912-A0AE7374-842A-4C88-B75B-F59AB32106AEQ57160461-D80BF637-DF33-404E-8E16-18A1F2BD62B7
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Monocyte fate in atherosclerosis
@ast
Monocyte fate in atherosclerosis
@en
Monocyte fate in atherosclerosis
@nl
type
label
Monocyte fate in atherosclerosis
@ast
Monocyte fate in atherosclerosis
@en
Monocyte fate in atherosclerosis
@nl
prefLabel
Monocyte fate in atherosclerosis
@ast
Monocyte fate in atherosclerosis
@en
Monocyte fate in atherosclerosis
@nl
P3181
P1476
Monocyte fate in atherosclerosis
@en
P2093
Clinton S Robbins
Ingo Hilgendorf
P304
P3181
P356
10.1161/ATVBAHA.114.303565
P407
P577
2015-02-01T00:00:00Z